Clinical and Electrocardiographic Differences in Brugada Syndrome With Spontaneous or Drug-Induced Type 1 Electrocardiogram.


Journal

Circulation journal : official journal of the Japanese Circulation Society
ISSN: 1347-4820
Titre abrégé: Circ J
Pays: Japan
ID NLM: 101137683

Informations de publication

Date de publication:
25 02 2019
Historique:
pubmed: 16 1 2019
medline: 31 3 2020
entrez: 16 1 2019
Statut: ppublish

Résumé

Spontaneous type 1 electrocardiogram (ECG) in the right precordial lead is a dominant predictor of ventricular fibrillation (VF) in Brugada syndrome (BrS). In some BrS patients with VF, however, spontaneous type 1 ECG is undetectable, even in repeated ECG and immediately after VF. This study investigated differences between BrS patients with spontaneous or drug-induced type 1 ECG. Methods and Results: We evaluated 15 BrS patients with drug-induced (D-BrS) and 29 with spontaneous type 1 ECG (SP-BrS). All patients had had a previous VF episode. In each D-BrS patient, ECG was recorded more than 15 times (mean, 46±34) during 7.2±5.1 years of follow-up. Age and family history were comparable between groups. Inferolateral early repolarization (ER) was observed in 13 D-BrS (87%) at least once but in only 3 SP-BrS (10%, P<0.01). Immediately after VF, inferolateral ER was accentuated in 9 of 10 D-BrS, while type 1 ECG was accentuated in 12 of 16 SP-BrS. Fragmented QRS in the right precordial lead and aVR sign were absent in D-BrS but present in 20 (69%, P<0.01) and 11 (38%, P<0.01) SP-BrS, respectively. There was no prognostic difference between groups. Although having similar clinical profiles, there are obvious ECG differences between VF-positive BrS patients with spontaneous or drug-induced type 1 ECG. The inferolateral lead rather than the right precordial lead on ECG may be particularly crucial in some BrS patients.

Sections du résumé

BACKGROUND
Spontaneous type 1 electrocardiogram (ECG) in the right precordial lead is a dominant predictor of ventricular fibrillation (VF) in Brugada syndrome (BrS). In some BrS patients with VF, however, spontaneous type 1 ECG is undetectable, even in repeated ECG and immediately after VF. This study investigated differences between BrS patients with spontaneous or drug-induced type 1 ECG. Methods and Results: We evaluated 15 BrS patients with drug-induced (D-BrS) and 29 with spontaneous type 1 ECG (SP-BrS). All patients had had a previous VF episode. In each D-BrS patient, ECG was recorded more than 15 times (mean, 46±34) during 7.2±5.1 years of follow-up. Age and family history were comparable between groups. Inferolateral early repolarization (ER) was observed in 13 D-BrS (87%) at least once but in only 3 SP-BrS (10%, P<0.01). Immediately after VF, inferolateral ER was accentuated in 9 of 10 D-BrS, while type 1 ECG was accentuated in 12 of 16 SP-BrS. Fragmented QRS in the right precordial lead and aVR sign were absent in D-BrS but present in 20 (69%, P<0.01) and 11 (38%, P<0.01) SP-BrS, respectively. There was no prognostic difference between groups.
CONCLUSIONS
Although having similar clinical profiles, there are obvious ECG differences between VF-positive BrS patients with spontaneous or drug-induced type 1 ECG. The inferolateral lead rather than the right precordial lead on ECG may be particularly crucial in some BrS patients.

Identifiants

pubmed: 30643106
doi: 10.1253/circj.CJ-18-0643
doi:

Substances chimiques

Anti-Arrhythmia Agents 0
Lidocaine 98PI200987
pilsicainide AV0X7V6CSE

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

532-539

Auteurs

Tomomi Nagayama (T)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.
Department of Cardiovascular Medicine, Fukuoka City Hospital.

Satoshi Nagase (S)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Tsukasa Kamakura (T)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Mitsuru Wada (M)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Kohei Ishibashi (K)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Yuko Y Inoue (YY)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Koji Miyamoto (K)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Takashi Noda (T)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Takeshi Aiba (T)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Hiroshi Takaki (H)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Masaru Sugimachi (M)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Wataru Shimizu (W)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.
Department of Cardiovascular Medicine, Nippon Medical School.

Teruo Noguchi (T)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Satoshi Yasuda (S)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Shiro Kamakura (S)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Kengo Kusano (K)

Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH